(redirected from adenomatous)
Also found in: Dictionary, Medical, Encyclopedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to adenoma

Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
References in periodicals archive ?
The grant will support a Phase 2a trial of the company's lead drug candidate, eRapa, in the treatment of the rare disease Familial Adenomatous Polyposis.
According to the classification by Kudo et al., 69 (38.5%) lesions had a non-neoplastic pit pattern (type I/II), 103 (57.6%) had an adenomatous pit pattern (type [III.sub.s]/[III.sub.L]/IV), and 7 (3.9%) had a cancerous pit pattern (type V/[V.sub.N] in terms of pit pattern (4).
Colorectal adenomatous polyps are precursor lesions of most colorectal tumors.
In addition, portions of the surface epithelium and superficial glands revealed adenomatous change.
Barney, "Adenomatous tumors of the middle ear and mastoid," Laryngoscope, vol.
Some identified risk factors include abdominal surgery/trauma, women of childbearing age (desmoid tumor growth is thought to be influenced by estrogen), and familial adenomatous polyposis/Gardner's Syndrome.
This study was conducted to assess the proliferative activity of adenomatous polyps using Ki-67.
Desmoid tumour biology in patients with familial adenomatous polyposis coli.
IT-102 will be further developed for treatment of familial adenomatous polyposis (FAP).
The most common type was the adenomatous polyp in 88(55.0%) cases followed by hyperplastic polyps 51(31.9%) and inflammatory polyps 21(13.1%).
Non-neoplastic and non-inflammatory lesion: Colloid goiter, adenomatous goiter, benign cystic lesion, hyperplasia, thyroglossal cyst, thyrotoxicosis.
Familial adenomatous polyposis (FAP) is an inherited disorder, which represents one of the most common gastrointestinal polyposis syndromes associated with colorectal tumorigenesis [1, 2].
In this study, we evaluated the distribution of NE cells in the prostatic transition zone (TZ), where adenomatous nodules mainly appear, according to the status of the adenoma in the TZ and estimated prostate volume (PV).
In addition, scientists at both companies see synergies between IthenaPharma's drugs and Marina's CEQ508 drug, unlocking its potential to treat not only familial adenomatous polyposis but colorectal cancer in general.